TABLE 3.
Summary of complications recorded in each study.
| Study and year | Wounds (n) | Number of complications | Complications |
|---|---|---|---|
| Wagstaff et al., April 2015, 16 | 10 | 7 | Infection under BTM–2 |
| Serous collection under BTM–2 | |||
| BTM failure–1 | |||
| Necrotic wound bed–1 | |||
| Infected donor site | |||
| Wagstaff et al., June 2015, 27 | 10 | 4 | Unrelated death–3 |
| Lost to follow up–1 | |||
| Greenwood et al., 2017 1 | 5 | 12 | Infection under BTM–2 |
| Contracture–3 | |||
| Haematoma under BTM–1 | |||
| BTM failure on shoulder–1 | |||
| Olecranon pressure ulcer–1 | |||
| Faecal contamination–1 | |||
| Necrotic wound bed–1 | |||
| Graft failure over malleoli–1 | |||
| Wagstaff et al., 2019, 4 | 7 | Not reported | Not reported |
| Solanki et al., 2020 11 | 25 | 11 | Infection–5 |
| Non‐adherence–3 | |||
| Incomplete vascularization–3 | |||
| Li et al., 2021, 5 | 35 | 6 | Infection under BTM–1 |
| Graft failure–2 | |||
| Haematoma–1 | |||
| Abdominal sinus–1 | |||
| Wound breakdown under graft–1 | |||
| Lo et al., 2021, 2 | 100 | 254 | Not detailed |
| Kuang et al., 2022, 19 | 18 | Not reported | Infection–22% 4 |
| Schlottmann et al., 2022, 7 | 27 | Not reported | Not reported |
| Wu et al., April 2022, 20 | 51 | 15 | Infection or cellulitis–9 |
| Dehiscence–2 | |||
| Haematoma or seroma–2 | |||
| Other–2 | |||
| Wu et al., July 2022, 28 | 5 | 1 | Infection–1 |
| Austin et al., 2023, 18 | 79 | Not reported | Infection–3 |
| Haematoma–2 | |||
| Cereceda‐monteoliva et al., 2023, 12 | 40 | 7 | Infection–5 |
| Non adherence–5 | |||
| Haematoma–1 | |||
| Delayed healing–1 | |||
| Osteomyelitis–1 | |||
| Seroma–1 | |||
| Concannon et al., 2023, 10 | 70 | 26 | Wound infection–7 |
| BTM loss–9 | |||
| Skin graft loss–7 | |||
| Amputation–2 | |||
| Tendon adhesions–2 | |||
| Haematoma–1 | |||
|
Tapking et al (REF) Feb 2024 |
300 | Not reported | Not reported |
| Struble et al., (REF), 2024 | 86 | 15 | Cellulitis or infection–4 |
| Haematoma or collection–7 | |||
| Early delamination–4 | |||
| Parker et al., (REF), July 2023 | 24 | 9 | Wound break down–2 |
| Overgranulation–1 | |||
| Graft loss–4 | |||
| Columella misalignment–1 | |||
| Necrotic wound base–1 | |||
| Meagher et al., (REF), March 2024 | 22 | Not reported | Not reported |
| Lo et al., (REF) May 2023 | 16 | Not reported | Not reported |
| Kidd et al., (REF), August 2023 | 37 | 19 | Total BTM loss–9 |
| Partial BTM loss–2 | |||
| Cellulitis–5 | |||
| Deep infection–2 | |||
| Haematoma–1 | |||
| Jou et al., (REF) May 2024 | 51 | 14 | Infection–5 |
| Harmatoma or sermoma–5 | |||
| Total BTM loss–3 | |||
| Partial BTM loss–1 | |||
| Heard et al., (REF), 2023 | 10 | 5 | Infection–4 |
| Haematoma–1 | |||
| Guerriero et al., Feb 2023 | 23 | 7 | Infection–3 |
| Minor amputation–3 | |||
| Major amputation–1 | |||
| Fuest et al., (REF), May 2023 | 27 | Not reported | Not reported |
| Devine et al., (REF), Feb 2024 | 12 | 9 | Infection–3 |
| Haematoma–3 | |||
| Failure of integration–2 | |||
| Delayed wound break down–1 | |||
| Chen et al., (REF), May 2024 | 37 | 10 | Infection–6 |
| BTM poor take–4 |
Abbreviation: BTM, biodegradable temporising matrix.